NCT02268435View on ClinicalTrials.gov

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

November 30, 2016

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

dovitinib plus imatinib

Dovitinib once daily on a 5 days on/2 days off dosing schedule, and imatinib once daily on a continuous dosing schedule

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER